Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6 -methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression. |

TÀI LIỆU LIÊN QUAN

Stage and tissue-specific prognostic impact of miR-182 in NSCLC

Psychosocial impact of prognostic genetic testing in uveal melanoma patients: A controlled prospective clinical observational study

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: Their relationships with clinicopathological characteristics and prognostic impact

The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer

Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis

Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.